Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Conner

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Toxicology and Applied Pharmacology|June 22, 2005
Metabolomic and proteomic biomarkers for III-V semiconductors: chemical-specific porphyrinurias and proteinuriasBruce A Fowler, Elizabeth A Conner, Hiroshi Yamauchi
Toxicology and Applied Pharmacology|March 21, 2008
Proteomic and metabolomic biomarkers for III-V semiconductors: and prospects for application to nano-materialsBruce A Fowler, Elizabeth A Conner, Hiroshi Yamauchi
Carcinogenesis|July 21, 2011
Genomic modeling of tumor onset and progression in a mouse model of aggressive human liver cancerCédric Coulouarn, Valentina M Factor, Elizabeth A Conner, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 29, 2004
Disregulation of E-cadherin in transgenic mouse models of liver cancerDiego F Calvisi, Sara Ladu, Elizabeth A Conner, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 15, 2003
Dysregulation of DNA repair pathways in a transforming growth factor alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesisKoji Hironaka, Valentina M Factor, Diego F Calvisi, et al.
Gastroenterology|May 8, 2004
Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic miceDiego F Calvisi, Valentina M Factor, Sara Ladu, et al.
Biochemical and Biophysical Research Communications|February 21, 2003
E2F1 blocks and c-Myc accelerates hepatic ploidy in transgenic mouse modelsElizabeth A Conner, Eric R Lemmer, Aránzazu Sánchez, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2004
Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repairChang-Goo Huh, Valentina M Factor, Aránzazu Sánchez, et al.
Gastroenterology|August 30, 2008
E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancerSara Ladu, Diego F Calvisi, Elizabeth A Conner, et al.
Journal of Hepatology|May 12, 2005
Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancerDiego F Calvisi, Elizabeth A Conner, Sara Ladu, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Toxicology and Applied Pharmacology|June 22, 2005
Metabolomic and proteomic biomarkers for III-V semiconductors: chemical-specific porphyrinurias and proteinuriasBruce A Fowler, Elizabeth A Conner, Hiroshi Yamauchi
Toxicology and Applied Pharmacology|March 21, 2008
Proteomic and metabolomic biomarkers for III-V semiconductors: and prospects for application to nano-materialsBruce A Fowler, Elizabeth A Conner, Hiroshi Yamauchi
Carcinogenesis|July 21, 2011
Genomic modeling of tumor onset and progression in a mouse model of aggressive human liver cancerCédric Coulouarn, Valentina M Factor, Elizabeth A Conner, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 29, 2004
Disregulation of E-cadherin in transgenic mouse models of liver cancerDiego F Calvisi, Sara Ladu, Elizabeth A Conner, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 15, 2003
Dysregulation of DNA repair pathways in a transforming growth factor alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesisKoji Hironaka, Valentina M Factor, Diego F Calvisi, et al.
Gastroenterology|May 8, 2004
Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic miceDiego F Calvisi, Valentina M Factor, Sara Ladu, et al.
Biochemical and Biophysical Research Communications|February 21, 2003
E2F1 blocks and c-Myc accelerates hepatic ploidy in transgenic mouse modelsElizabeth A Conner, Eric R Lemmer, Aránzazu Sánchez, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2004
Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repairChang-Goo Huh, Valentina M Factor, Aránzazu Sánchez, et al.
Gastroenterology|August 30, 2008
E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancerSara Ladu, Diego F Calvisi, Elizabeth A Conner, et al.
Journal of Hepatology|May 12, 2005
Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancerDiego F Calvisi, Elizabeth A Conner, Sara Ladu, et al.
Pageof 5